Vis enkel innførsel

dc.contributor.authorMichelsen, Brigitte
dc.contributor.authorBerget, Kristine Thomassen
dc.contributor.authorKavanaugh, Arthur
dc.contributor.authorHaugeberg, Glenn
dc.date.accessioned2023-03-08T13:13:31Z
dc.date.available2023-03-08T13:13:31Z
dc.date.created2022-08-08T13:28:51Z
dc.date.issued2022
dc.identifier.citationRheumatology and therapy. 2022, 9 (4), 1171-1179.en_US
dc.identifier.issn2198-6576
dc.identifier.urihttps://hdl.handle.net/11250/3057096
dc.language.isoengen_US
dc.rightsNavngivelse-Ikkekommersiell 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/deed.no*
dc.titleAssociation between TNFi anti-drug antibodies, smoking, and disease activity in patients with inflammatory arthritis: Results from a Norwegian cross-sectional observational studyen_US
dc.title.alternativeAssociation between TNFi anti-drug antibodies, smoking, and disease activity in patients with inflammatory arthritis: Results from a Norwegian cross-sectional observational studyen_US
dc.typeJournal articleen_US
dc.typePeer revieweden_US
dc.description.versionpublishedVersionen_US
dc.source.pagenumber1171-1179en_US
dc.source.volume9en_US
dc.source.journalRheumatology and therapyen_US
dc.source.issue4en_US
dc.identifier.doi10.1007/s40744-022-00464-7
dc.identifier.cristin2041733
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse-Ikkekommersiell 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse-Ikkekommersiell 4.0 Internasjonal